Isoprenoids, small GTPases and Alzheimer's disease
- 8 April 2010
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1801 (8) , 896-905
- https://doi.org/10.1016/j.bbalip.2010.03.014
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Statins: drugs for Alzheimer’s disease?Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2005
- Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCKPLoS Medicine, 2005
- Activation of NADPH oxidase and extracellular superoxide production in seizure‐induced hippocampal damageJournal of Neurochemistry, 2004
- Insig-dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-CoA Reductase Stimulated by Sterols and GeranylgeraniolJournal of Biological Chemistry, 2003
- Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer’s diseaseNeuroReport, 2003
- Regulating Access to the GenomeCell, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Cholesterol and pathological processes in Alzheimer's diseaseJournal of Neuroscience Research, 2002
- Variations of hepatic dolichols during rat developmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Regulation of the mevalonate pathwayNature, 1990